Glucosephosphate Dehydrogenase
"Glucosephosphate Dehydrogenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D005954
|
| MeSH Number(s) |
D08.811.682.047.150.300
|
| Concept/Terms |
Glucosephosphate Dehydrogenase- Glucosephosphate Dehydrogenase
- Dehydrogenase, Glucosephosphate
- Glucose-6-Phosphate Dehydrogenase
- Dehydrogenase, Glucose-6-Phosphate
- Glucose 6 Phosphate Dehydrogenase
|
Below are MeSH descriptors whose meaning is more general than "Glucosephosphate Dehydrogenase".
Below are MeSH descriptors whose meaning is more specific than "Glucosephosphate Dehydrogenase".
This graph shows the total number of publications written about "Glucosephosphate Dehydrogenase" by people in this website by year, and whether "Glucosephosphate Dehydrogenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 9 | 1 | 10 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Glucosephosphate Dehydrogenase" by people in Profiles.
-
G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19. Pharmacogenomics J. 2021 12; 21(6):649-656.
-
Management of children with glucose-6-phosphate dehydrogenase deficiency presenting with acute haemolytic crisis during the SARs-COV-2 pandemic. Vox Sang. 2022 Jan; 117(1):80-86.
-
COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients. Nucleosides Nucleotides Nucleic Acids. 2021; 40(5):505-517.
-
Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin. Clin Nutr ESPEN. 2021 06; 43:197-199.
-
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19). Free Radic Res. 2021 Apr; 55(4):364-374.
-
Evaluation of glucose-6-phosphate dehydrogenase (G6PD) status in US military and VA patients with COVID-19 infection. BMJ Mil Health. 2021 Apr; 167(2):144.
-
The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19. Free Radic Biol Med. 2020 12; 161:84-91.
-
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out. Eur J Intern Med. 2020 10; 80:103.
-
Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal. Eur J Intern Med. 2020 10; 80:101-102.
-
Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase-deficient patient with COVID-19 infection. Eur J Haematol. 2020 10; 105(4):512-513.